Correlation Between Green Cures and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Green Cures and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Green Cures and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Green Cures Botanical and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on Green Cures and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Green Cures with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Green Cures and Takeda Pharmaceutical.
Diversification Opportunities for Green Cures and Takeda Pharmaceutical
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Green and Takeda is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Green Cures Botanical and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and Green Cures is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Green Cures Botanical are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of Green Cures i.e., Green Cures and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between Green Cures and Takeda Pharmaceutical
Given the investment horizon of 90 days Green Cures Botanical is expected to generate 14.03 times more return on investment than Takeda Pharmaceutical. However, Green Cures is 14.03 times more volatile than Takeda Pharmaceutical Co. It trades about 0.2 of its potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.02 per unit of risk. If you would invest 0.02 in Green Cures Botanical on September 1, 2024 and sell it today you would earn a total of 0.00 from holding Green Cures Botanical or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 99.21% |
Values | Daily Returns |
Green Cures Botanical vs. Takeda Pharmaceutical Co
Performance |
Timeline |
Green Cures Botanical |
Takeda Pharmaceutical |
Green Cures and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Green Cures and Takeda Pharmaceutical
The main advantage of trading using opposite Green Cures and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Green Cures position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.Green Cures vs. Cann American Corp | Green Cures vs. Rimrock Gold Corp | Green Cures vs. Galexxy Holdings | Green Cures vs. Indoor Harvest Corp |
Takeda Pharmaceutical vs. Astellas Pharma | Takeda Pharmaceutical vs. Daiichi Sankyo | Takeda Pharmaceutical vs. Chugai Pharmaceutical Co | Takeda Pharmaceutical vs. Bayer AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |